Remifentanil is a powerful opioid analgesic that is primarily used during surgical procedures. Remifentanil is ultra short-acting, and its effects wear off more quickly than other opioids, making it preferred when a quick recovery is optimal. [1][2] Remifentanil is a highly addictive opioid, but it is not commonly abused due to its highly restricted access because it is typically administered only in hospitals and surgical centers. [3]
- Remifentanil is an opioid analgesic that can be administered intravenously to keep a patient comfortable during certain invasive medical procedures or surgeries.
- Remifentanil has a shorter half-life than most opioids, meaning its effects wear off quickly.
- While opioids are highly addictive and carry a high risk of misuse, overdose, and withdrawal, this medication is not prescribed for at-home use, restricting its ability to be recreationally abused.
What is Remifentanil?
Remifentanil is an opioid analgesic medication that is administered intravenously for pain relief or combined with other anaesthetics to induce sleep during surgical procedures. Unlike other opioids, Remifentanil is not metabolized by the liver, making it safer for patients with existing liver problems or dysfunction. [1][2] This medication is typically only administered during medical procedures and surgeries that are performed in hospitals and surgical centers, and is not available for at-home administration. [3]
Remifentanil is available generically or under the brand name Ultiva and has been FDA-approved for over two decades. [1] This drug is especially effective for procedures where patients need to recover quickly after a procedure. Because Remifentanil is metabolized by non-specific tissue and plasma esterases instead of by the liver, its effects wear off quickly. After stopping the IV, patients wake up and become alert within a few minutes, which makes it preferred for certain medical procedures. [1][2]
How Remifentanil works
Remifentanil is an opioid analgesic medication that works by binding to mu-opioid receptors in the brain. These receptors are involved in pain management, which is why opioids are often utilized during invasive medical procedures like surgeries. Remifentanil is often combined with other medications and anesthesia to help patients remain asleep and comfortable during surgeries or medical procedures that require anesthesia. [1]
Remifentanil is an ultra-short-acting medication and has a half-life of only a few minutes, meaning its effects wear off quickly. While this can hasten the process of waking up after anesthesia, secondary administration of another opioid is sometimes needed to help manage post-procedure pain. [2]
Common side effects & safety profile
Remifentanil belongs to a family of drugs called opioid analgesics, and has similar side effects and safety warnings to other drugs in its class. Like other opioids, this medication slows a person’s breathing and carries a black box warning for risk of respiratory depression. During procedures, medical professionals will monitor vital signs and intervene to prevent these effects from becoming life-threatening. [2]
In addition to the risk for respiratory depression, other Remifentanil side effects include: [1][2]
- Low blood pressure
- Drop in heart rate
- Dizziness and confusion
- Muscle rigidity (including rigid chest syndrome)
- Nausea
- Itching
- Pruritis
- Constipation
- Shivering
Serious risks, overdose, & hyperalgesia
There are risks associated with the use of Remifentanil, including the risk for addiction, tolerance, overdose, and respiratory depression. These risks are relatively uncommon, since the medication is typically only administered as a single dose during inpatient procedures and surgeries. [1][2][4] Some patients are particularly sensitive to the effects of opioids and may be more likely to experience serious adverse effects after being given Remifentanil. This is especially true among the elderly and the frail, where the dosage must typically be reduced.
Some research suggests that because this medication is so short-acting, it carries an increased risk for tolerance and can induce temporary withdrawal symptoms. [4][5] Individuals with a history of opioid dependence and withdrawal are likely at higher risk for these adverse effects. In certain people, hyperalgesia was reported during the withdrawal phase of this medication. [5] Hyperalgesia is a temporary increase in perceived pain and sensitivity, which can increase the amount of discomfort following a procedure.
Low potential for misuse
Remifentanil is not prescribed for at-home use, so there are no significant reports of the medication being recreationally abused or available to the public. Typically, this medication is only administered in inpatient and outpatient medical centers that perform surgeries and other invasive medical procedures requiring anesthesia. While it is an addictive drug, its limited availability has prevented people from being able to access it for recreational use. [3]
Dependence and withdrawal
Remifentanil does not normally cause withdrawals because of its short half-life and the fact that it is not prescribed for ongoing or long-term use. It is possible that opioid users could experience withdrawal as a result of abusing other opioids before or after being given Remifentanil. [3][4][5]
Opioid withdrawal is uncomfortable and commonly involves symptoms such as sweating and shivering, flu-like symptoms, muscle cramping and pain, gastrointestinal pain, diarrhea or cramps, feeling anxious or irritable, insomnia, and sleep difficulties, etc.
Safety & monitoring
Remifentanil is an intravenous opioid that is given as a single administration during surgical and medical procedures. During these procedures, a patient’s vital signs are continuously monitored.
Because Remifentanil is an ultra-short-acting medication, its effects wear off quickly, and people regain full consciousness within minutes. This makes it a preferred medication for quick outpatient medical procedures and surgeries because patients do not need to be monitored for long after waking up. The terminal half-life of Remifentanil is only 10-20 minutes, after which point the drug is completely eliminated from the system. [1][2]
If the medication caused a dangerous drop in blood pressure or respiration, attending nurses and doctors would intervene and administer the drug naloxone, which can quickly reverse the effects of the medication and prevent overdose. [2][3]
In the event that an individual did gain access to the drug and self-administer it, there would be a high potential for accidental overdose. Opioid overdoses can induce respiratory depression, which is a life-threatening condition that requires emergency administration of naloxone to prevent death. [3]
Alternatives & recovery-oriented approach
Some people with a history of addiction or opioid dependence may not want to receive Remifentanil during a medical procedure because of the risk of relapse, withdrawal, or addiction. If you or a loved one has a history of opioid dependence, talk openly with your doctor before undergoing a procedure where you are given an opioid like Remifentanil. There may be alternative medications or anesthetics that are safer and more appropriate alternatives.
When to seek help
If you are struggling with an active addiction to an opioid, there are treatment options available. Many individuals are able to establish their recovery with a combination of therapy and medications like suboxone or methadone, which can reduce cravings and withdrawal symptoms.
-guide-detail.jpg?v=1722503283)
_-Historical-and-Current-Use-in-Pain-Management-guide-detail.jpg?v=1745315297)
